临床试验用品市场基于(主要区域、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00009672
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

临床试验用品市场规模预计将从 2023 年的 381936 万美元增至 2031 年的 808587 万美元。预计 2024-2031 年该市场的复合年增长率为 9.9%。随着药物发现成本的不断增加,临床试验供应变得越来越重要。此外,对启动临床试验的一类生物医药产品实行更严格的办理要求,临床试验供应策略也需要不断完善。全球临床试验用品市场的增长  归因于制药和生物制药公司研发支出增加、临床试验数量增加以及发达国家药物开发成本上升等关键驱动因素。然而,由于冠状病毒的负面影响,药物开发和临床试验成本的上升以及临床试验面临的挑战预计将在预测几年内抑制市场增长。全球慢性疾病的显着增长可能仍将是临床试验用品市场的趋势。CAGR of 9.9% in 2024–2031. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance. In addition, implementing more stringent handling requirements for a type of biopharmaceutical product starting clinical trials and clinical trial supplies strategy needs to be continuously improved. The growth of the global biopharmaceutical companies, increase in the number of clinical trials, and higher costs of drug development in developed nations. However, the rising cost of drug development and clinical trials and challenges for clinical trials due to the coronavirus's negative impact are expected to restrain the market growth during the forecast years. The significantly growing chronic diseases across the world are likely to remain a clinical trial supplies market trend.

 

临床试验用品市场分析

亚太发展中国家不断增长的医疗保健行业为临床试验用品管理市场参与者扩大业务创造了更好的机会。这些国家庞大的患者群体正在产生对更多临床试验的需求。在亚太地区进行的临床试验比在美国或欧洲进行的临床试验还要多。这种转变归因于较低的运营成本、巨大的患者招募潜力、合同研究组织的发展、有利的监管环境以及更好的临床试验能力和质量。在北美和欧洲等发达地区,约35%的试验因患者招募问题而被推迟,五分之一的试验因受试者不足而被拒绝入组。根据《亚洲临床试验:世界卫生组织数据库研究》报告,2008年至2017年,伊朗进行的临床试验数量年均增长41.9%,斯里兰卡增长27.1%,中国增长23.3% ,印度为21.3%,日本为18.4%,泰国为14.7%,马来西亚为8.4%,韩国为12.9%。enrolment due to insufficient subjects. As per the report “Clinical Trials in Asia: A World Health Organization database study,” from 2008 to 2017, the average yearly rise in the number of clinical trials conducted was 41.9% in Iran, 27.1% in Sri Lanka, 23.3% in China, 21.3% in India, 18.4% in Japan, 14.7% in Thailand, 8.4% in Malaysia, and 12.9% in Korea.

临床试验供应市场参与者数量的增加预计将推动全球临床试验供应市场。

 

临床试验用品市场概述

临床试验是一项调查研究,旨在确定某种医疗方法、疗法或设备对于人类应用是否有效、安全和有用。这些研究有助于找到最适合某些疾病的治疗方法。临床试验用品管理对于避免生产过剩、供应过剩和库存过期是必要的。

慢性病患病率的上升推动了临床试验用品市场的增长。

 

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

临床试验用品市场:

临床试验用品市场

  • 年均复合增长率(2024 - 2031)
    9.9%
  • 2023年市场规模
    381936万美元
  • 2031年市场规模
    808587万美元

市场动态

增长动力
  • 庞大的患者群体产生了临床试验的需求
未来的趋势
  • 慢性病发病率增加
机会
  • 从服务提供商和合同研究组织外包临床试验

关键人物;主力;重要一员

  • 赛默飞世尔科技
  • 康泰伦特
  • 欧陆科技
  • 皮拉马尔制药解决方案
  • PRA 健康科学
  • Marken(UPS 子公司)
  • 精锐国际公司
  • 比奥凯尔
  • 阿尔马克集团
  • 夏普包装服务

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

产品与服务
  • 制造业
  • 包装和标签
  • 物流配送
阶段
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 生物等效性研究
药品类型
  • 小分子药物 生物药物
应用
  • 肿瘤学
  • 心血管疾病
  • 神经系统疾病
  • 呼吸系统疾病
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

临床试验用品市场驱动因素和机遇

 

慢性病高发利好市场

亚洲慢性病的高发病率是可能导致亚洲临床试验数量激增的一个关键因素。据世界卫生组织 (WHO) 称,非传染性疾病导致该地区总死亡人数的 55%,每年约 800 万人。此外,制药公司可能会分别在中国或韩国进行治疗胃食管癌或 肝癌的药物试验 ,因为这些国家有许多患有这些疾病的患者。此外,亚洲的临床试验费用比美国和欧盟低约 30-40%,因为亚洲国家的医生就诊、医疗治疗和手术费用较低。预计这一因素将增加临床试验,从而促进临床试验用品市场的增长。

 

外包临床试验服务

将临床试验外包  给合同制造商和服务提供商,为药品制造商提供了充足的时间来开发其他药物制剂,与其他制药公司保持频繁和持续的沟通,并预防风险和其他好处。 Fisher Clinical Services, Inc.、PAREXEL International 和 Piramal Pharma Solutions 等公司为制药和生物制药公司提供物流和分销服务。因此,上述因素导致了临床试验用品市场规模的增长。

 

临床试验用品市场报告细分分析

有助于临床试验用品市场分析的关键部分是产品和服务以及阶段。

  • 根据产品和服务,市场分为制造、包装和标签以及物流和分销。 2023年,物流与配送领域占据最大市场份额;预计该细分市场在预测期内将实现市场上最高的复合年增长率。由于制药行业合同制造的不断增长,物流和分销部门预计将成为按产品和服务计算的最大部门。临床试验过程所需的成本要高得多。制药和生物制药公司投入大量资金来严格处理临床试验过程中的制药操作。因此,各制药公司将临床试验外包,以避免因生产过剩、供应过剩和库存过期而产生不必要的处理成本。因此,这些因素导致了临床试验供应和物流市场的增长。
  • 根据阶段,临床试验用品市场分为 I ​​期、II 期、III 期和生物等效性研究。第三阶段细分市场在 2023 年占据最大的市场份额,预计在预测期内将实现市场最高的复合年增长率。 III期临床试验阶段是针对大型患者群体进行的。 III期临床试验阶段有助于确定活性药物成分的短期和长期疗效。因此,对配制药物的总治疗值和相关治疗值进行评估。由于三期临床试验涉及患者众多,因此保持药物的有效性、安全性和准确性非常重要,否则可能会导致药物对许多注册三期临床试验的患者产生不良反应。 Shertech Manufacturing 就是这样一家提供 III 期临床试验服务的公司,它为客户提供与疗效和副作用相关的全面、明确的数据。它还有助于遵守 FDA 标准,进一步协助将药物引入市场并完成所需的许可申请。因此,疼痛管理对临床试验用品市场做出了贡献,预计在预测期内将继续这一趋势。

 

按地域划分的临床试验用品市场份额分析

临床试验用品市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲、南美洲和中美洲。

根据地理位置,临床试验用品市场分为五个主要区域:北美、欧洲、亚太地区、南美洲和中美洲以及中东和非洲。我们根据三个主要国家——美国、加拿大和墨西哥对北美临床试验用品市场进行了分析。据估计,美国临床试验供应市场在预测期内将占据最大的市场份额。美国临床试验用品市场的增长归因于该地区提供制造、存储、物流和其他服务的市场参与者的存在,这可能会促进该国的市场增长。例如,Alderley Analytical、Almac 等都是著名的制造组织,为 600 多家制药和生物技术公司提供广泛的综合服务。此外,孤儿和罕见疾病领域对服务和药品的需求增长预计将鼓励药品制造商开发智能药品并招募患者进行临床试验。国家对新药开发的日益迫切也预计将增加行业进入者的数量,以跟上制药行业的快速步伐。

 

临床试验用品市场报告范围

报告属性细节
2023年市场规模381936万美元
2031 年市场规模808587万美元
全球复合年增长率(2024 - 2031)9.9%
历史数据2021-2022
预测期2024-2031
涵盖的细分市场按产品和服务
  • 制造业
  • 包装和标签
  • 物流配送
按阶段
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 生物等效性研究
按药物类型
  • 小分子药物 生物药物
按申请
  • 肿瘤学
  • 心血管疾病
  • 神经系统疾病
  • 呼吸系统疾病
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 赛默飞世尔科技
  • 康泰伦特
  • 欧陆科技
  • 皮拉马尔制药解决方案
  • PRA 健康科学
  • Marken(UPS 子公司)
  • 精锐国际公司
  • 比奥凯尔
  • 阿尔马克集团
  • 夏普包装服务
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

临床试验用品市场新闻和最新动态

临床试验用品市场是通过收集初级和二级研究后的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。以下是创新、业务扩展和战略市场发展的列表:

  • 2020 年 5 月,UDG Healthcare 旗下夏普从美国质量包装专家国际公司 (QPSI) 购买了一家药品包装设施。这座占地 160,000 平方英尺的工厂位于宾夕法尼亚州麦坎吉,为客户提供初级和二级药品包装服务。 Macungie 工厂提供装瓶、起泡、小瓶贴标、医疗器械配套和 灭菌服务(来源:夏普,新闻稿)
  • 2021 年 4 月,康泰伦特在其费城临床供应服务设施中增加了低温能力。此次扩张有助于提高康泰伦特在临床试验用低温材料的基因治疗、包装、标签和分销方面的能力(来源:康泰伦特公司,新闻稿)

 

临床试验用品市场报告范围和可交付成果

《临床试验用品市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

  • 临床试验用品范围内所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,例如驱动因素、限制因素和关键机遇
  • 临床试验用品市场趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 临床试验用品市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 临床试验用品行业格局和竞争分析,包括市场集中度、热图分析、知名企业和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports